SCHEMBL25544622

SCHEMBL25544622

N#Cc1ccc(-c2ccc(N(c3ccc(-c4nc5ccccc5o4)cc3)c3ccc(-c4cccc5c4oc4ccccc45)cc3)cc2)cc1C#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
NPC1 O15118 5/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
TP53 P04637 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
RAB9A P51151 3/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37
HSPD1 P10809 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPN5 P54829 1/20 0.36
HSPE1 P61604 1/20 0.36
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.35
MAPT P10636 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25543489 0.95 ALOX5 (0.39) ALOX5NPC1ALDH1A1KDM4EHPGD
SCHEMBL25544526 0.89 ALOX5 (0.47) ALOX5ALDH1A1KDM4EATMLMNA
SCHEMBL23328768 0.89 ALOX5 (0.47) ALOX5ALDH1A1KDM4EATMLMNA
SCHEMBL25544169 0.89 NPC1 (0.40) ALOX5NPC1ALDH1A1KDM4EHPGD
SCHEMBL25544453 0.88 NPC1 (0.40) ALOX5NPC1ALDH1A1KDM4EHPGD
SCHEMBL25543239 0.88 NPC1 (0.41) ALOX5NPC1ALDH1A1KDM4EHPGD
SCHEMBL25543726 0.87 ALOX5 (0.45) ALOX5ALDH1A1KDM4EATMLMNA
SCHEMBL25544697 0.87 ALOX5 (0.45) ALOX5ALDH1A1KDM4EATMLMNA
SCHEMBL25544833 0.87 NPC1 (0.48) NPC1ALDH1A1KDM4EHPGDTP53
SCHEMBL23328455 0.87 NPC1 (0.48) ALOX5NPC1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
EP-4183784-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Lapto Co., Ltd. (KR) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SAT1, FTO, SETDB1 ALOX5 2036/4885NPC1 2875/4885ALDH1A1 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.